Wird geladen...

Second primary malignancies after autologous hematopoietic cell transplantation for multiple myeloma

Recent studies demonstrate an increased risk of second primary malignancies (SPM) in multiple myeloma (MM) patients on maintenance lenalidomide following autologous stem cell transplantation (ASCT). There may be other risk factors driving SPM post-ASCT in MM, so we explored this possibility through...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Krishnan, Amrita Y., Mei, Matthew, Sun, Can-Lan, Thomas, Sandra H., Berano Teh, Jennifer, Kang, Tongjun, Htut, Myo, Somlo, George, Sahebi, Firoozeh, Forman, Stephen J., Bhatia, Smita
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2012
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3553262/
https://ncbi.nlm.nih.gov/pubmed/23073267
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2012.09.023
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!